Vincent Gies

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series.

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series.

Journal: Annals of the rheumatic diseases

Published: December 18, 2025

Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055].

Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055].

Journal: Molecular pharmacology

Published: September 19, 2025

Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects.

Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects.

Journal: Molecular pharmacology

Published: February 15, 2025

The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models.

The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models.

Journal: Frontiers in immunology

Published: September 03, 2024

Correction: An immunogenomic exome landscape of triple positive primary antiphospholipid patients.

Correction: An immunogenomic exome landscape of triple positive primary antiphospholipid patients.

Journal: Genes and immunity

Published: March 20, 2024

CXCR4: from B-cell development to B cell-mediated diseases.

CXCR4: from B-cell development to B cell-mediated diseases.

Journal: Life science alliance

Published: October 30, 2023

Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome.

Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome.

Journal: Nature communications

Published: October 17, 2023

Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling.

Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling.

Journal: Immunity

Published: September 09, 2023

An immunogenomic exome landscape of triple positive primary antiphospholipid patients.

An immunogenomic exome landscape of triple positive primary antiphospholipid patients.

Journal: Genes and immunity

Published: August 16, 2023

Complex Allele with Additive Gain-of-Function STING1 Variants in a Patient with Cavitating Lung Lesions and Aspergillosis.

Complex Allele with Additive Gain-of-Function STING1 Variants in a Patient with Cavitating Lung Lesions and Aspergillosis.

Journal: Journal of clinical immunology

Published: May 03, 2021

Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy.

Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy.

Journal: Frontiers in immunology

Published: April 16, 2021

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.

Journal: Autoimmunity reviews

Published: January 29, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026